Clinical Trial Search Results
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients with Hyperfiltration
This study is currently enrolling.
7700-2019-02: Improving Oncology Population Health Management in Prostate Cancer through Patient Reported Outcomes (PRO) and Care4Today
This study is currently enrolling.
The purpose of this study is to assess how the integration of a mobile application (Care4Today Connect), use of a survivorship care plan, and goal setting in the oncology clinic workflow can affect patients' health related ...
A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver or Nonalcoholic Steatohepatitis
This study is currently enrolling.
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH or NAFL in clinical practice. TARGET-NASH will create a carefully maintained, actively monitored research registry of patients with NAF ...
A double-blind, randomised, placebo-controlled, parallel group trial to evaluate the efficacy and safety of empagliflozin and linagliptin over 24 weeks, with a double-blind active treatment safety extension period to 52 weeks, in children and adolescents with type 2 diabetes mellitus
This study is currently enrolling.
This study is being done to: (a) compare the safety and effects of the study drugs, called empagliflozin and linagliptin with a placebo, in children and adolescents with type 2 diabetes, during the first 25 weeks of this study. ...
A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia
This study is currently enrolling.
[Shell Only]-HUD/CUD.
A Mixed Methods Evaluation of a Resilience Intervention with Psychoeducational Sessions for Critical Care Nurses
This study is currently enrolling.
The ongoing nursing shortage in the U.S health care system is a multifaceted issue. One factor leading to the nursing shortage is high turnover. Consequences of turnover and low nurse staffing include lower quality of care, low ...
A Multicenter, Open-Label, Phase Ⅱ Clinical Trial to Evaluate the Safety and Efficacy of TTAC-0001, a Fully Human Monoclonal Antibody in Patients with Recurrent Glioblastoma Progressed on Bevacizumab Including Therapy
This study is currently enrolling.
The aim of this study is to assess the safety and effectiveness of the study drug, TTAC-0001 to patients with recurrent glioblastoma which has progressed on bevacizumab treatment. Another aim is to measure the levels of TTAC-00 ...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 52-Week Maintenance and an Open Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis Who Responded to Induction Treatment in M16-067 or M16-065
This study is currently enrolling.
The purpose of this study is to evaluate the efficacy and safety of Risankizumab versus placebo and determine how well it works as maintenance therapy and long-term therapy for subjects with moderate to severe ulcerative coliti ...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to evaluate the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy
This study is currently enrolling.
The purpose of this study is to evaluate the efficacy and safety of risankizumab and determine how well it works in subjects with moderate to severe ulcerative colitis.